Inactivation of Endothelial Small/Intermediate Conductance of Calcium-Activated Potassium Channels Contributes to Coronary Arteriolar Dysfunction in Diabetic Patients

J Am Heart Assoc. 2015 Aug 24;4(8):e002062. doi: 10.1161/JAHA.115.002062.

Abstract

Background: Diabetes is associated with coronary arteriolar endothelial dysfunction. We investigated the role of the small/intermediate (SK(Ca)/IK(Ca)) conductance of calcium-activated potassium channels in diabetes-related endothelial dysfunction.

Methods and results: Coronary arterioles (80 to 150 μm in diameter) were dissected from discarded right atrial tissues of diabetic (glycosylated hemoglobin = 9.6±0.25) and nondiabetic patients (glycosylated hemoglobin 5.4±0.12) during coronary artery bypass graft surgery (n=8/group). In-vitro relaxation response of precontracted arterioles was examined in the presence of the selective SK(Ca)/IK(Ca) activator NS309 and other vasodilatory agents. The channel density and membrane potential of diabetic and nondiabetic endothelial cells was measured by using the whole cell patch-clamp technique. The protein expression and distribution of the SK(Ca)/IK(Ca) in the human myocardium and coronary arterioles was examined by Western blotting and immunohistochemistry. Our results indicate that diabetes significantly reduced the coronary arteriolar response to the SK(Ca)/IK(Ca) activator NS309 compared to the respective responses of nondiabetic vessels (P<0.05 versus nondiabetes). The relaxation response of diabetic arterioles to NS309 was prevented by denudation of endothelium (P=0.001 versus endothelium-intact). Diabetes significantly decreased endothelial SK(Ca)/IK(Ca) currents and hyperpolarization induced by the SK(Ca)/IK(Ca) activator NS309 as compared with that of nondiabetics. There were no significant differences in the expression and distribution of SK(Ca)/IK(Ca) proteins in the coronary microvessels.

Conclusions: Diabetes is associated with inactivation of endothelial SK(Ca)/IK(Ca) channels, which may contribute to endothelial dysfunction in diabetic patients.

Keywords: coronary microcirculation; coronary microvascular function; diabetes mellitus; potassium channels; vascular endothelial function.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Arterioles / drug effects
  • Arterioles / metabolism*
  • Arterioles / physiopathology
  • Biomarkers / blood
  • Case-Control Studies
  • Cells, Cultured
  • Coronary Artery Disease / diagnosis
  • Coronary Artery Disease / metabolism*
  • Coronary Artery Disease / physiopathology
  • Coronary Vessels / drug effects
  • Coronary Vessels / metabolism*
  • Coronary Vessels / physiopathology
  • Diabetic Angiopathies / diagnosis
  • Diabetic Angiopathies / metabolism*
  • Diabetic Angiopathies / physiopathology
  • Dose-Response Relationship, Drug
  • Down-Regulation
  • Endothelial Cells / drug effects
  • Endothelial Cells / metabolism*
  • Female
  • Glycated Hemoglobin / analysis
  • Humans
  • Intermediate-Conductance Calcium-Activated Potassium Channels / agonists
  • Intermediate-Conductance Calcium-Activated Potassium Channels / metabolism*
  • Male
  • Membrane Potentials
  • Middle Aged
  • Signal Transduction
  • Small-Conductance Calcium-Activated Potassium Channels / agonists
  • Small-Conductance Calcium-Activated Potassium Channels / metabolism*
  • Vasodilation* / drug effects
  • Vasodilator Agents / pharmacology

Substances

  • Biomarkers
  • Glycated Hemoglobin A
  • Intermediate-Conductance Calcium-Activated Potassium Channels
  • Small-Conductance Calcium-Activated Potassium Channels
  • Vasodilator Agents
  • hemoglobin A1c protein, human